首页> 外文期刊>General Pharmacology >A unique xanthine derivative KMCP-98 with activation of adenosine receptor subtypes.
【24h】

A unique xanthine derivative KMCP-98 with activation of adenosine receptor subtypes.

机译:独特的黄嘌呤衍生物KMCP-98,具有腺苷受体亚型的激活作用。

获取原文
获取原文并翻译 | 示例
       

摘要

KMCP-98 is a newly synthesized adenosine receptor agonist by alkylation at the 7-position of the xanthines nucleus. We first investigated the pharmacological activities of KMCP-98 under in vivo and in vitro conditions. Acute intravenous injection of KMCP-98 (1.0, 2.0 and 3.0 mg/kg) produced a temporary fall in blood pressure and heart rate, followed by a sustained fall in heart rate in pentobarbital-anesthetized Wistar rats. The hypotensive and bradycardiac responses were inhibited by pretreatment with an A(1) adenosine receptor antagonist 8-phenyltheophylline (8-PT, 0.5 mg/kg). Both KMCP-98 and adenosine (0.3-100 microM) produced negative inotropic activity in isolated guinea pig left atria. The negative inotropic activity of KMCP-98 was significantly blocked by pretreatment with A(1) receptor antagonists 8-PT (10 microM) and xanthine amine congener (XAC, 10 microM), a nonselective adenosine antagonist theophylline (10 microM), a K(+) channel blocker tetraethylammonium (TEA, 10 mM) and a K(ATP) channel blocker glibenclamide (1 microM). KMCP-98 (0.03-30 microM) produced concentration-dependent relaxations in carbachol (1 microM) precontracted guinea pig tracheal smooth muscle. The trachea relaxant response of KMCP-98 was markedly inhibited by A(2), A(2a) and A(2b) adenosine receptor antagonists 3,7-dimethyl-1-propargylxanthine (DMPX, 10 microM), 8-(3-chlorostyryl)caffeine (CSC, 10 microM) and alloxazine (10 microM), respectively, the nitric oxide synthase (NOS) inhibitor L-NAME (100 microM) and also by TEA and glibenclamide. In addition, KMCP-98 (0.03-30 microM) elicited relaxant response in norepinephrine (3 microM) precontracted rat thoracic aorta in a concentration-dependent manner. The thoracic aorta relaxant response of KMCP-98 was also significantly inhibited by DMPX, CSC, alloxazine, L-NAME, TEA and glibenclamide. Furthermore, the binding characteristics of KMCP-98, adenosine and 5'-N-ethylcarboxaminoadenosine (NECA) were evaluated in [(3)H]DPCPX and [(3)H]CGS 21680 binding to rat cortex and striatum, respectively. The K(i) values of KMCP-98 for predominate A(1) and A(2) adenosine receptor sites were 3908+/-952 and 158+/-10 nM, respectively. In conclusion, KMCP-98 was found to be a xanthine-based adenosine receptor agonist associated cardiac depression, tracheal and aortic smooth muscle relaxations.
机译:KMCP-98是一种新合成的腺嘌呤受体激动剂,通过在黄嘌呤核的7位烷基化。我们首先研究了在体内和体外条件下KMCP-98的药理活性。 KMCP-98的急性静脉注射(1.0、2.0和3.0 mg / kg)导致血压和心率暂时下降,随后戊巴比妥麻醉的Wistar大鼠心率持续下降。通过用A(1)腺苷受体拮抗剂8-苯基茶碱(8-PT,0.5 mg / kg)进行预处理可抑制低血压和心动过缓反应。 KMCP-98和腺苷(0.3-100 microM)在离体豚鼠左心房均产生负性肌力活性。 KMCP-98的负性肌力活性被A(1)受体拮抗剂8-PT(10 microM)和黄嘌呤胺同类物(XAC,10 microM),一种非选择性腺苷拮抗剂茶碱(10 microM),K (+)通道阻滞剂四乙铵(TEA,10 mM)和K(ATP)通道阻滞剂格列本脲(1 microM)。 KMCP-98(0.03-30 microM)在卡巴胆碱(1 microM)预收缩的豚鼠气管平滑肌中产生浓度依赖性的松弛。 KMCP-98的气管舒张反应明显受到A(2),A(2a)和A(2b)腺苷受体拮抗剂3,7-二甲基-1-炔丙基黄嘌呤(DMPX,10 microM),8-(3-氯苯乙烯基(CSC,10 microM)和Alloxazine(10 microM)分别是一氧化氮合酶(NOS)抑制剂L-NAME(100 microM)以及TEA和格列本脲。此外,KMCP-98(0.03-30 microM)以浓度依赖性方式在去甲肾上腺素(3 microM)预收缩大鼠胸主动脉中引起松弛反应。 DMPX,CSC,阿洛嗪,L-NAME,TEA和格列本脲也明显抑制KMCP-98的胸主动脉松弛反应。此外,分别在[(3)H] DPCPX和[(3)H] CGS 21680与大鼠皮层和纹状体的结合中评估了KMCP-98,腺苷和5'-N-乙基羧氨基腺苷(NECA)的结合特性。 KMCP-98的主要A(1)和A(2)腺苷受体位点的K(i)值分别为3908 +/- 952和158 +/- 10 nM。总之,发现KMCP-98是一种基于黄嘌呤的腺苷受体激动剂,可引起心脏抑郁,气管和主动脉平滑肌松弛。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号